Etemad, M.; Christodoulou, F.; Uhlig, S.; Hassel, J.C.; Schrotz-King, P.; Brenner, H.; Ulrich, C.M.; Bieback, K.; Klüter, H.; Bugert, P.
C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy Controls. Cancers 2023, 15, 5514.
https://doi.org/10.3390/cancers15235514
AMA Style
Etemad M, Christodoulou F, Uhlig S, Hassel JC, Schrotz-King P, Brenner H, Ulrich CM, Bieback K, Klüter H, Bugert P.
C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy Controls. Cancers. 2023; 15(23):5514.
https://doi.org/10.3390/cancers15235514
Chicago/Turabian Style
Etemad, Mani, Foteini Christodoulou, Stefanie Uhlig, Jessica C. Hassel, Petra Schrotz-King, Hermann Brenner, Cornelia M. Ulrich, Karen Bieback, Harald Klüter, and Peter Bugert.
2023. "C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy Controls" Cancers 15, no. 23: 5514.
https://doi.org/10.3390/cancers15235514
APA Style
Etemad, M., Christodoulou, F., Uhlig, S., Hassel, J. C., Schrotz-King, P., Brenner, H., Ulrich, C. M., Bieback, K., Klüter, H., & Bugert, P.
(2023). C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy Controls. Cancers, 15(23), 5514.
https://doi.org/10.3390/cancers15235514
